Vietnam kicks off trials for second homegrown vaccine candidate
Country's first coronavirus inoculation is headed for emergency approval in May
HANOI -- Vietnam has begun first-phase clinical trials for its second domestically developed coronavirus vaccine just months before the expected approval of the initial homegrown candidate.
Some 120 volunteers ages 18-59 will receive doses of Covivac, with a second shot administered after a 28-day window.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapterFind out more
Free access for everyone - Sep. 30